...
首页> 外文期刊>Biotechnology Advances: An International Review Journal >Current challenges facing one-step production of ce:small-caps>l/ce:small-caps>-ascorbic acid
【24h】

Current challenges facing one-step production of ce:small-caps>l/ce:small-caps>-ascorbic acid

机译:电流面临的挑战面临的一步生产& Ce:小帽> L& / ce:小帽> - 血红蛋白

获取原文
获取原文并翻译 | 示例
           

摘要

l-ascorbic acid (L-AA, vitamin C) is an essential vitamin that is widely used as a nutrient or medicine in the pharmaceuticals, cosmetics, food, beverage and feed additive industries, and accounts for the largest share of the global vitamins market. L-AA is mainly produced by a classic two-step fermentation process that suffers from the use of a multi-step mixed culture system and two rounds of sterilisation, which significantly increases the cost of the final product. One-step fermentation has been attempted, but a method rivalling the efficiency of the two-step process has not yet been achieved on an industrial scale. In this review, based on the current classical two-step fermentation processes and other potential routes for L-AA production, the challenges and pitfalls of a one-step fermentation process are summarised. The prospects for one-step fermentation production of L-AA and how this might be achieved are also discussed.
机译:L-抗坏血酸(L-AA,维生素C)是一种基本的维生素,广泛用作药品,化妆品,食品,饮料和饲料添加剂行业的营养素或药物,并占全球维生素市场的最大份额 。 L-AA主要由经典的两步发酵过程产生,这些过程遭受了多步混合培养系统和两轮灭菌,这显着增加了最终产品的成本。 已经尝试了一步发酵,但竞争对竞争的方法尚未在工业规模上实现两步过程的效率。 在本综述中,基于目前的经典两步发酵过程和L-AA生产的其他潜在路线,总结了一步发酵过程的挑战和陷阱。 还讨论了L-AA的一步发酵生产的前景以及如何实现这一目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号